This inventor holds 1 USPTO granted patent. Top assignee: Nantong University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Jue Ling in Biomedical Engineering
Introduction: Jue Ling is a notable inventor based in Nantong, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of hemostatic agents. His innovative work aims to address critical medical challenges, enhancing patient care and treatment outcomes.
Latest Patents: Jue Ling holds a patent for a hemostatic agent designed for jaw central hemangioma hemorrhage. The patent describes a preparation method that involves the reaction of chitosan powder and organic weak acid in organic alcohol to create a chitosan weak acid salt. This hemostatic agent exhibits excellent fluidity and plasticity, allowing it to effectively reach the site of hemorrhage without causing tissue damage. Additionally, it has antibacterial properties, which help prevent cross-infection and facilitate easy cleaning and removal. This invention is poised for clinical promotion due to its effectiveness in treating massive hemorrhages associated with jaw central hemangioma.
Career Highlights: Jue Ling is affiliated with Nantong University, where he continues to engage in research and development in biomedical engineering. His work has garnered attention for its practical applications in medical settings, particularly in surgical procedures involving hemostasis.
Collaborations: Jue Ling collaborates with Jiang Zhu, contributing to advancements in their shared field of expertise. Their partnership enhances the research and development efforts at Nantong University.
Conclusion: Jue Ling's innovative contributions to biomedical engineering, particularly through his patented hemostatic agent, demonstrate his commitment to improving medical treatments. His work not only addresses immediate clinical needs but also paves the way for future advancements in the field.